메뉴 건너뛰기




Volumn 6, Issue 8, 2002, Pages 649-650

Should tuberculosis programmes invest in second-line treatments for multidrug-resistant tuberculosis (MDR-TB)?

Author keywords

[No Author keywords available]

Indexed keywords

TUBERCULOSTATIC AGENT;

EID: 0035992351     PISSN: 10273719     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Short Survey
Times cited : (12)

References (11)


* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.